Baudax Bio, Inc. (BXRX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.05M |
| Enterprise Value | 2.91M |
| P/E Ratio | -0 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -0 |
| Enterprise/Revenue | 1.47 |
| Enterprise/EBITDA | -0.06 |
Fiscal Year
| Fiscal Year | December 31, 2022 |
| Most Recent Quarter | September 30, 2023 |
Profitability
| Profit Margin | -46.33 |
| Operating Margin | -44.77 |
AD
Management Effectiveness
| Return On Assets | -5.86 |
| Return On Equity | 10.67 |
Income Statement
| Revenue | 1.27M |
| Revenue/Share | 3.83 |
| Gross Profit | -5.74M |
| EBITDA | -35.58M |
| Net Income | -58.8M |
| Diluted EPS | -177.3 |
Balance Sheet
| Total Cash | 363,000 |
| Total Cash/Share | 15.86 |
| Total Debt | 8.1M |
| Total Debt/Equity | -0.29 |
| Current Ratio | 0.3 |
| Book Value Per Share | -73.1 |
Price History
| 52-Week Change | -98.73 |
| 52-Week High | 3.47 |
| 52-Week Low | 0.01 |
| Moving Average 50 Days | 0.02 |
| Moving Average 200 Days | 0.29 |
Statistics
| Average Volume | 424,847 |
| Shares Outstanding | 0 |
| % Held by Institutions | 0.01 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:40 |
| Last Split Date | December 01, 2022 |
AD
